These findings raise the possibility that the neuroprotective effects of TIM-3 deficiency may involve CD28+PU.1low microglia, and that the coordinated activity of lymphoid-associated receptor gene expression in plaque-associated microglia underlies neuroprotection in AD. This evidence concerns the gene CD28 and Alzheimer disease.